Pangaea Oncology, S.A. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EUR 1.1 million compared to EUR 0.951873 million a year ago. Net loss was EUR 0.927342 million compared to net income of EUR 0.094668 million a year ago.